Document Type : Case Report


1 Department of Emergency Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

2 Department of Emergency Medicine, Mashhad University of Medical Sciences, Mashhad, Iran


Objective: We are going to alert the emergency physicians to be aware of drugs side effects. Some drugs like methotrexate are not routine drugs, and the symptoms may be miss diagnosed if not completely notified.
Case Presentation: We present two patients under treatment with methotrexate. Both of them suffered from methotrexate poisoning due to improper use. We discuss the causes of methotrexate poisoning and its prevention.
Conclusion: A significant proportion of methotrexate users may not be completely aware of its proper use and the side effects. One of the important ways to prevent the toxicity of methotrexate is educating patients and their companions in order to use it correctly.


Main Subjects

1. Singh A, Handa AC. Medication error- a case report of misadventure with methotrexate. JNMA J Nepal Med Assoc 2018; 56(211): 711-5.
2. Feinsilber D, Leoni RJ, Siripala D, Leuck J, Mears KA. Evaluation, identification, and management of acute methotrexate toxicity in high-dose methotrexate administration in hematologic malignancies. Cureus 2018; 10(1): e2040. doi: 10.7759/cureus.2040.
3. Howard SC, McCormick J, Pui CH, Buddington RK, Harvey RD. Preventing and managing toxicities of highdose methotrexate. Oncologist 2016; 21(12): 1471-82. doi:10.1634/theoncologist.2015-0164.
4. Elmorsi YM, El-Haggar SM, Ibrahim OM, Mabrouk MM. Effect of ketoprofen and indomethacin on methotrexate pharmacokinetics in mice plasma and tumor tissues. Eur J Drug Metab Pharmacokinet 2013; 38(1): 27-32. doi:10.1007/s13318-012-0113-x.
5. Knoll K, Anzengruber F, Cozzio A, French LE, Murer C, Navarini AA. Mucocutaneous ulcerations and pancytopenia due to methotrexate overdose. Case Rep Dermatol 2016;8(3): 287-93. doi: 10.1159/000446692.
6. Lindsay K, Fraser AD, Layton A, Goodfield M, Gruss H, Gough A. Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy. Rheumatology (Oxford) 2009; 48(5):569-72. doi: 10.1093/rheumatology/kep023.
7. Gaies E, Jebabli N, Trabelsi S, Salouage I, Charfi R, Lakhal M, et al. Methotrexate side effects: review article. J Drug Metab Toxicol 2012; 3(4): 125. doi: 10.4172/2157-7609.1000125.
8. Widemann BC, Adamson PC. Understanding and managing methotrexate nephrotoxicity. Oncologist 2006;11(6): 694-703. doi: 10.1634/theoncologist.11-6-694.
9. Prey S, Paul C. Effect of folic or folinic acid supplementation on methotrexate-associated safety and efficacy in inflammatory disease: a systematic review. Br J Dermatol 2009; 160(3): 622-8. doi: 10.1111/j.1365-2133.2008.08876.x.